Annual Cancer Screening: Which Tests Are Really Annual, When to Get Them, and How to Stay on Track

The phrase “annual cancer screening” is used casually — by patients, by providers, and in health media — in ways that often don’t match what screening guidelines actually say. Some cancer tests truly are annual. Many are not. And the confusion between the two leads to people either getting tested too often or assuming they’re covered when they’re not.

The real goal of cancer screening is not to be tested every single year. It is to be “up-to-date” — meaning your most recent screening falls within the recommended interval for your age, sex, and risk profile. For some tests, that means every year. For others, it means every 3, 5, or even 10 years. Understanding the difference is the first step to building a screening schedule you can actually maintain.

Which Cancer Screenings Are Truly Annual?

A small number of recommended cancer screening tests are designed to be performed once a year. These are:

Mammography (breast cancer): The USPSTF recommends annual mammography for women ages 40–74 (Grade B, updated 2024). The annual interval reflects the biology of breast cancer in premenopausal women — tumors can grow significantly within a year, and the interval is calibrated to catch cancers at a stage where treatment is most effective.

Breast MRI (high-risk women only): Women with BRCA1 or BRCA2 mutations, prior chest radiation before age 30, or an estimated lifetime breast cancer risk of 20% or higher by a validated model (Tyrer-Cuzick, BOADICEA) are recommended annual breast MRI in addition to annual mammography, beginning at age 25–30 depending on the specific risk factor.

Low-dose CT (LDCT) for lung cancer: Adults ages 50–80 who currently smoke or quit within the past 15 years and have at least a 20 pack-year smoking history qualify for annual LDCT under USPSTF Grade B (2021). The annual interval is essential — lung cancer can advance rapidly, and a single baseline scan does not provide ongoing protection.

Fecal immunochemical test (FIT) for colorectal cancer: FIT is one of the accepted colorectal cancer screening methods and is performed annually. It is a stool-based test that detects blood in the stool. A positive FIT requires follow-up colonoscopy. For patients who cannot or prefer not to undergo colonoscopy, annual FIT is a fully endorsed alternative with comparable effectiveness if completed consistently.

PSA (prostate cancer, if elected): Men ages 55–69 who choose to pursue PSA testing after shared decision-making (USPSTF Grade C) typically follow an annual or every-1–2-year schedule in clinical practice, guided by their provider.

Liver cancer surveillance (high-risk patients): This is not a population screening but a surveillance protocol for patients with cirrhosis or chronic hepatitis B — populations at significantly elevated hepatocellular carcinoma (HCC) risk. Abdominal ultrasound every 6 months is the standard recommendation.

Annual full-body skin exam (high-risk patients): The USPSTF gives skin cancer screening an “I” (insufficient evidence) rating for average-risk adults. However, the American Academy of Dermatology (AAD) recommends annual full-body skin exams for patients with a history of skin cancer, atypical moles, or significant sun or UV exposure history.

The Tests That Are NOT Annual (But People Think They Are)

Several cancer screening tests are commonly misunderstood as annual. Knowing the correct intervals prevents both over-screening and false reassurance from tests done too infrequently.

Colonoscopy: every 10 years, not every year. A normal colonoscopy in an average-risk adult is valid for 10 years. There is no benefit to more frequent colonoscopy in the absence of polyp findings or risk factors. If a colonoscopy finds low-risk adenomatous polyps, the follow-up interval moves to 3–5 years. High-risk or multiple polyps: 1–3 years. These shorter intervals are surveillance protocols, not standard population screening.

Pap smear and HPV testing: every 3–5 years. Cervical cancer screening is not annual. USPSTF recommends Pap smear alone every 3 years (ages 21–29), and either Pap alone every 3 years, HPV test alone every 5 years, or HPV+Pap co-test every 5 years (ages 30–65). Annual Pap smears are not recommended and do not improve outcomes compared to appropriate-interval screening.

Cologuard (stool DNA test): every 1–3 years. Cologuard is approved for 1–3 year intervals (FDA), with ACS specifying every 3 years. It is more sensitive than FIT but requires less frequent use.

The “annual physical” is not cancer screening. A general physical examination — even if done annually — does not automatically include cancer screening. A provider may refer for screenings during a physical, but the physical itself is distinct from mammography, colonoscopy, or LDCT. Cancer screening tests are ordered separately and require their own appointments.

Cancer Screening Adherence: Where the Gaps Are

Knowing what tests to get and actually getting them are different things. Adherence to recommended cancer screening is imperfect across all major cancer sites, with some gaps more severe than others.

Colorectal cancer: Approximately 72% of adults ages 50–75 are up-to-date on colorectal cancer screening (CDC, 2021) — leaving roughly 28% unscreened. Colorectal cancer is highly preventable; colonoscopy can remove precancerous polyps before they become cancer, and the American Cancer Society estimates that up to 68% of colorectal cancer deaths could be prevented with regular screening.

Lung cancer: Only 4–16% of adults who qualify for annual LDCT screening actually receive it — one of the most severe adherence gaps in preventive medicine. Lung cancer kills more Americans than breast, prostate, and colorectal cancer combined, and LDCT is the only screening test shown to reduce lung cancer mortality.

Breast cancer: Approximately 77% of women ages 50–74 had a mammogram in the past 2 years (CDC, 2021). Black women have a 40% higher breast cancer mortality rate than white women — a disparity driven partly by access barriers to screening and follow-up care.

Cervical cancer: Roughly 78–80% of women ages 21–65 are up-to-date on cervical cancer screening. The gap is disproportionately concentrated in uninsured and underinsured women — cervical cancer remains largely a disease of inadequately screened populations.

Why People Fall Behind (and What to Do About It)

No symptoms, no urgency. Cancer screening is for people who feel well. The entire design of screening is to catch cancer before it causes symptoms — but the absence of symptoms removes the most obvious motivator to seek care. The solution is making screening scheduled and systematic, not reactive.

Cost and coverage confusion. Many patients are unsure whether their insurance will cover a specific test. USPSTF Grade A and B services are covered without cost-sharing under most ACA-compliant plans. Calling the insurance member services line to confirm coverage before scheduling removes this barrier.

Fear of bad results. Avoidance of screening due to fear of finding cancer is well-documented and more common among people with personal or family experience with cancer. A direct, non-judgmental conversation with a primary care provider about fear — including what early detection actually changes — is often the most effective intervention.

Colonoscopy prep anxiety. Bowel preparation is a significant deterrent. For patients who cannot or will not undergo colonoscopy, annual FIT is a highly effective alternative — and any stool test completed every year is far better than a colonoscopy perpetually postponed.

No primary care anchor. Without a regular primary care relationship, no one is tracking a patient’s screening calendar. Establishing care with a primary care provider — even for a single preventive visit — creates the accountability structure that keeps screening on schedule.

The Annual Wellness Visit: Your Screening Anchor

The most practical strategy for maintaining a cancer screening schedule is anchoring it to a recurring annual appointment. Two formal structures exist:

Medicare Annual Wellness Visit (AWV): Covered at $0 under Medicare Part B. The AWV is a health risk assessment and prevention planning visit — not a hands-on physical examination. It includes review of medical and family history, medications, cognitive assessment, depression screening, blood pressure, and — critically — personalized prevention planning with referrals for any overdue cancer screenings.

ACA Annual Preventive Visit (private insurance): ACA-compliant insurance plans cover an annual preventive visit without cost-sharing. Screening referrals generated at this visit — mammography, colonoscopy, LDCT — are separately covered as preventive services when billed correctly.

What to Accomplish at the Annual Visit

1. Ask: “Which cancer screenings am I due for based on my age and risk factors?”
2. Share any new family history (a parent or sibling newly diagnosed with cancer changes your risk profile)
3. Obtain referrals for any overdue screenings
4. Review prior screening results and any follow-up needed
5. Discuss any screening conversations you’ve been putting off (PSA, LDCT)

Building Your Personal Screening Calendar

A personal screening calendar doesn’t require any special tool — a phone note, patient portal document, or simple dated notebook works perfectly. The key is having one place where dates of completed screenings are recorded so you can calculate when each is next due.

* ACS/NCCN recommendation — not USPSTF rated. † AAD recommendation — USPSTF Grade I for average-risk adults.

Tracking Tips

• Use your primary care patient portal (MyChart, etc.) to view dates of prior labs and procedures
• After each screening, note the date and interval in a personal health file
• Set a recurring annual calendar reminder (“Mammogram — schedule in October”) so you remember to book, not just that it’s due
• Link colonoscopy reminders to a memorable annual event — a birthday or anniversary — so the due year is easy to recall

Getting Back on Track After a Gap

For most tests: Simply schedule the test as soon as possible. If your last mammogram was 3 years ago and you’re due annually, schedule one now. If your FIT was 2 years ago, order one now. There is no “restart” requirement — your screening history doesn’t reset.

Cervical cancer screening after a long gap (5–10+ years): A gap of this length warrants a conversation with your provider. Depending on your age and prior HPV testing history, you may simply resume standard intervals — or your provider may want to assess your current HPV status before setting the next schedule.

Colonoscopy if never screened and now age 55+: Schedule one without delay. If colonoscopy is not feasible, start annual FIT immediately — any colorectal screening beats none.

Lung LDCT if you’ve never been screened: If you meet eligibility criteria (ages 50–80, 20+ pack-year history, currently smoking or quit within 15 years), schedule one now. The first LDCT requires a shared decision-making discussion as a Medicare requirement — ask your primary care provider for a referral.

Talking to Your Doctor About Your Screening Schedule

Most cancer screenings require a provider referral or order. Initiating the conversation is the patient’s responsibility if it doesn’t come up naturally.

How to start: “I want to make sure I’m up-to-date on all the cancer screenings I should be having at my age. Can we go through them together?” This is a completely appropriate request at any primary care or internal medicine visit.

Five Questions That Open the Conversation

1. “Am I up-to-date on colorectal, breast/prostate, cervical, and lung cancer screening?”
2. “Based on my smoking history, do I qualify for lung cancer CT screening?”
3. “My [family member] was recently diagnosed with [cancer type]. Does that change my schedule?”
4. “What’s the most convenient test option for colorectal cancer if I want to avoid colonoscopy for now?”
5. “How will I be notified of results, and what happens if something is flagged?”

Frequently Asked Questions

This article is for educational purposes only and does not constitute medical advice. Cancer screening decisions should be made in consultation with a qualified healthcare provider based on your individual health history, risk factors, and personal circumstances.